BRIEF published on 08/06/2024 at 10:05, 1 year 9 months ago QUANTRO Therapeutics obtient une subvention de recherche autrichienne clé pour faire progresser le développement de la plateforme Découverte De Médicament QUANTRO Thérapeutique Bourse FFG Plateforme Transcriptomique Multiplexage
PRESS RELEASE published on 08/06/2024 at 10:00, 1 year 9 months ago QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform QUANTRO Therapeutics secures Austrian research grant to accelerate cutting-edge platform development, enabling multiplex target screening in drug discovery Drug Discovery QUANTRO Therapeutics Austrian Research Grant Transcriptomic Discovery Platform Multiplexing Capabilities
BRIEF published on 06/04/2024 at 23:12, 1 year 11 months ago QUANTRO Therapeutics Reaches Milestone in Collaboration with Boehringer Ingelheim Cancer Treatments R&D Collaboration Boehringer Ingelheim QUANTRO Therapeutics Transcription Factors
BRIEF published on 06/04/2024 at 23:12, 1 year 11 months ago QUANTRO Therapeutics franchit une étape importante en collaboration avec Boehringer Ingelheim Boehringer Ingelheim QUANTRO Thérapeutique Traitements Contre Le Cancer Facteurs De Transcription Collaboration R&D
PRESS RELEASE published on 06/04/2024 at 23:07, 1 year 11 months ago QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments QUANTRO Therapeutics achieves key milestone in collaboration with Boehringer Ingelheim for first-in-class cancer treatments using proprietary technology Cancer Treatments Boehringer Ingelheim QUANTRO Therapeutics Transcription Factors R&D Program
PRESS RELEASE published on 04/04/2023 at 09:30, 3 years 1 month ago QUANTRO Therapeutics appoints Industry Expert Dr. Michael Bauer as Chief Executive Officer
Published on 05/28/2026 at 01:15, 5 hours 24 minutes ago JM Capital II Corp. Announces Departure of President, Chief Financial Officer and Chief Financial Officer Jay Freeman
Published on 05/28/2026 at 00:55, 5 hours 44 minutes ago First Helium Closes Oversubscribed $2.6 Million Placement
Published on 05/27/2026 at 23:42, 6 hours 57 minutes ago New Horizon Aircraft Ltd. Announces Closing of $25 Million Offering of Common Shares
Published on 05/27/2026 at 23:05, 7 hours 34 minutes ago Vox Royalty Announces Annual and Special Meeting Results
Published on 05/27/2026 at 23:05, 7 hours 34 minutes ago Avino Reports Voting Results of Its 2026 Annual General Meeting
Published on 05/27/2026 at 23:29, 7 hours 9 minutes ago Market entry in Brazil: DEUTZ expands its energy business in Latin America
Published on 05/27/2026 at 23:09, 7 hours 29 minutes ago EQS-Adhoc: DEUTZ AG acquires Brazilian generator manufacturer Maxi Trust Power Ltda.
Published on 05/27/2026 at 20:52, 9 hours 46 minutes ago EQS-Adhoc: REPLOID Group AG: Procedural deficiencies related to the appointment of auditors in prior periods require remediation. Publication of the 2025 Annual Statements delayed.
Published on 05/27/2026 at 20:32, 10 hours 6 minutes ago Sirma Group Holding AD reports strong profitability growth in Q1 2026
Published on 05/27/2026 at 19:55, 10 hours 43 minutes ago IGEL Brings Now & Next Workspace & Endpoint Security Summits to Five European Cities
Published on 05/27/2026 at 23:00, 7 hours 39 minutes ago BIOPHYTIS MODIFIE SA LIGNE DE FINANCEMENT AVEC HEXAGON CAPITAL FUND POUR RENDRE RENOUVELABLE SA CAPACITE DE TIRAGE DE 2M€
Published on 05/27/2026 at 23:00, 7 hours 39 minutes ago BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Published on 05/27/2026 at 20:28, 10 hours 10 minutes ago Combined Shareholders’ Meeting of May 27, 2026
Published on 05/27/2026 at 17:45, 12 hours 54 minutes ago Imerys-05-2026-communique-capital-droits-de-vote-au-30-avril-2026
